Exploring Molecules Linked to Eye Inflammation and Retinal Damage
Administrative Supplement: Glutathionylated Products of Radical-Induced Lipid Oxidation in Inflammatory Disease
This project aims to understand how certain molecules, called pseudo leukotrienes, contribute to eye conditions like age-related macular degeneration by studying them in the retina.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Case Western Reserve University NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project ID | NIH-11321907 on NIH RePORTER |
What this research studies
Our eyes can experience damage from processes like lipid oxidation, which creates specific molecules called pseudo leukotrienes (øLTs). These øLTs are similar to other inflammatory molecules and are found in the human retina, especially after oxidative stress. We believe these øLTs might contribute to eye conditions such as age-related macular degeneration. To learn more, we are using advanced equipment to measure these molecules and observe their effects in models of retinal degeneration. This work helps us understand how these molecules affect eye health and could guide future treatments.
Who could benefit from this research
Good fit: Patients with retinal diseases, such as age-related macular degeneration, may eventually benefit from the knowledge gained from this fundamental research.
Not a fit: Patients without retinal conditions or those whose conditions are not related to lipid oxidation may not directly benefit from this specific line of research.
Why it matters
Potential benefit: If successful, this work could lead to a better understanding of retinal diseases and potentially new ways to prevent or treat conditions like age-related macular degeneration.
How similar studies have performed: While the role of similar inflammatory molecules (leukotrienes) in retinal pathology is known, the specific contribution of pseudo leukotrienes (øLTs) is a novel area of investigation.
Where this research is happening
Cleveland, United States
- Case Western Reserve University — Cleveland, United States (Active)
Researchers
- Principal investigator: Salomon, Robert Gerd — Case Western Reserve University
- Study coordinator: Salomon, Robert Gerd
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.